Trial Profile
Comparison of tenofovir or entecavir monotherapy with lamivudine in patients with decompensated chronic hepatitis B (dCHB)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2015 New trial record